Get started
Author

Maria Teresa Ionta

Observed names: Ionta MT, Ionta, Maria, Ionta, Maria Teresa, M T Ionta, M. Ionta, M. T. Ionta, M.T. Ionta, M.T. Maria Teresa Ionta, MARIA TERESA IONTA, Maria T Ionta
OpenAlex ID: A5110082669
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
2014 · E. Bajetta, I. Floriani, et al. · Annals of Oncology · 92
PDF
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
2017 · A Ruzzo, F Graziano, et al. · British Journal of Cancer · 72
PDF
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
2016 · Grazia Palomba, Valentina Doneddu, et al. · Journal of Translational Medicine · 64
PDF
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
2016 · S. Lonardi, A. Sobrero, et al. · Annals of Oncology · 59
PDF
Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
2015 · Fabiana Pani, Francesco Atzori, et al. · Thyroid · 46
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
2014 · Annamaria Ruzzo, Francesco Graziano, et al. · Scientific Reports · 44
PDF
Targeting insulin-like growth factor type 1 receptor in cancer therapy
2009 · Francesco Atzori, Tiffany A. Traina, et al. · Targeted Oncology · 43
Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)
2000 · M. Costantini, E. Mencaglia, et al. · Quality of Life Research · 36
A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer.
2002 · S Tomao, A Romiti, et al. · PubMed · 31
Clinical Activity and Cardiac Tolerability of Non-Pegylated Liposomal Doxorubicin in Breast Cancer: A Synthetic Review
2011 · Mario Airoldi, Dino Amadori, et al. · Tumori Journal · 22
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
2019 · Annamaria Ruzzo, Francesco Graziano, et al. · Scientific Reports · 18
PDF
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia
2014 · GRAZIA PALOMBA, MARIO BUDRONI, et al. · Oncology Letters · 18
PDF
Allergy and Tumour Outcome after Primary Cancer Therapy
2004 · Raffaello Pompei, Giorgio Lampis, et al. · International Archives of Allergy and Immunology · 17
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 · Gerardo Rosati, Sara Lonardi, et al. · European Journal of Cancer · 16
Meeting psychosocial and health information needs to ensure quality of cancer care in outpatients
2017 · Maria Francesca Piazza, Maura Galletta, et al. · European Journal of Oncology Nursing · 16
Is There a Role for Adjuvant Immunochemotherapy after Radical Nephrectomy in pT2-3N0M0Renal Cell Carcinoma?
1995 · R. Migliari, G. Muscas, et al. · Journal of Chemotherapy · 16
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population
2015 · Grazia Palomba, Angela Loi, et al. · BMC Cancer · 15
PDF
Usefulness of pyridinium crosslinks and CA 15-3 as markers in metastatic bone breast carcinoma.
1996 · B Massidda, M T Ionta, et al. · PubMed · 14
Negative Prognostic Factors and Resulting Clinical Outcome in Patients with Metastatic Renal Cell Carcinoma Included in the Italian Nivolumab-Expanded Access Program
2018 · Sergio Bracarda, Luca Galli, et al. · Future Oncology · 13
Prevention of Delayed Emesis by a Single Intravenous Bolus Dose of 5-HT3-Receptor- Antagonist in Moderately Emetogenic Chemotherapy
1996 · B. Massidda, M.T. Ionta · Journal of Chemotherapy · 12
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting
2017 · Daniele Generali, Filippo Montemurro, et al. · The Oncologist · 11
PDF
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
2016 · Grazia Palomba, Antonio Cossu, et al. · Oncology Letters · 10
PDF
Jejunal Obstruction Caused by Metastasis from an Undiagnosed Breast Cancer: A Case Report
2012 · Pietro Giorgio Calò, Daniela Fanni, et al. · Tumori Journal · 10
Undescribed Case of Necrotic Ulcerative Amyopathic Dermatomyositis in Bone Metastatic Breast Cancer
2008 · Valeria Pusceddu, Barbara Frau, et al. · The Breast Journal · 8
Inflammatory breast cancer in Italy
2010 · Maria Teresa Ionta, Francesco Atzori, et al. · Cancer · 6
PDF
Works count: 57
Citation count: 743
H-index: 16
I10-index: 23
Year
Topic
Type